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	Abstract  
 
Clostridium difficile can be a major problem in hospitals because the bacterium 
primarily affects individuals with an altered intestinal flora; this largely occurs through 
prolonged antibiotic use.  Proposed sources of increased community-acquired infections 
are food animals and retail meats.  The objective of this study was to compare the 
antimicrobial resistance patterns of C. difficile isolated from a closed, integrated 
population of humans and swine to increase understanding of the bacterium in these 
populations.  Swine fecal samples were collected from a vertically flowing swine 
population consisting of farrowing, nursery, breeding, and grower/finisher production 
groups.  Human wastewater samples were collected from swine worker and non-worker 
occupational group cohorts.  Antimicrobial susceptibility testing was performed on 523 
C. difficile strains from the population using commercially available agar diffusion 
Epsilometer test (Etest) for 11 different antimicrobials.  All of the swine and human 
strains were susceptible to amoxicillin/clavulanic acid, piperacillin/tazobactam, and 
vancomycin.  In addition, all the human strains were susceptible to chloramphenicol.  The 
majority of the human and swine strains were resistant to cefoxitin and ciprofloxacin.  
Statistically significant differences in antimicrobial susceptibility were found among the 
swine production groups for ciprofloxacin, tetracycline, amoxicillin/clavulanic acid, and 
clindamycin.  No significant differences in antimicrobial susceptibility were found across 
human occupational group cohorts. We found that 8.3% of the swine strains and 13.3% 
of the human strains exhibited resistance to metronidazole.  The finding of differences in 
susceptibility patterns between human and swine strains of C. difficile, provides evidence 
that transmission between host species in this integrated population is unlikely.   
	Introduction  
 
 Clostridium difficile is one of the most common causes of nosocomial infections 
(Vonberg et al., 2008).  This anaerobic, Gram-positive bacterium produces spores that are 
both heat- and alcohol-resistant, and therefore easily transferred between patients and 
equipment in hospitals and nursing homes (Weir and Flegel, 2005).  Clostridium difficile 
primarily affects individuals with an altered intestinal flora, following periods of 
prolonged antibiotic use.  Patients infected with C. difficile experience symptoms ranging 
from diarrhea to severe cases of colitis that may result in death (Kuijper et al., 2006).  
 The most common risk factor for C. difficile infection is antibiotic use and the risk 
of infection is increased if the bacteria are resistant to antimicrobial drugs (Gerding, 
2004).  One of the primary identifying characteristics of the NAP1/ribotype 
027/toxinotype III virulent strain, responsible for recent outbreaks, is resistance to 
clindamycin (Fenner et al., 2008; Kuijper et al., 2008).  Patterns of C. difficile infection 
occurring after antibiotic use have been well documented throughout the years.  In the 
1970s, C. difficile was first associated with the use of clindamycin, leading health care 
practitioners to decrease use (Gerding, 2004).  Fluoroquinolone use began in the late 
1980s and in 2001 a study linked ciprofloxacin, a commonly prescribed fluoroquinolone, 
to C. difficile infection (Yip et al., 2001).   
Treatment of C. difficile is difficult because of its direct causal relationship with 
antibiotic use.  The two most commonly prescribed antibiotics for C. difficile infection 
are metronidazole and vancomycin.  Resistance of C. difficile to metronidazole or 
vancomycin may lead to treatment failure or relapses of infection (Pituch et al., 2005).  
Resistance to metronidazole appears to be increasing.  Often an initial treatment with 
	metronidazole is unsuccessful and subsequent treatment with vancomycin is needed 
(Huang et al., 2009b).  However, the majority of published studies have found no 
resistance to either vancomycin or metronidazole among C. difficile isolated from clinical 
cases or the environment (Huang et al., 2009a; Taori et al., 2010).   
Recent C. difficile studies have focused on the apparent increase in outbreaks due 
to NAP1/ribotype 027/toxinotype III strain infections (Drudy et al., 2008; McDonald et 
al., 2005) and an increased incidence of community-acquired infections (CDC, 2008; 
Huang et al., 2009c).  By definition, these community-acquired cases have no history of 
recent hospital exposure (Huang et al., 2009c).  Understanding the evolution and source 
of these strains is crucial for both treatment and prevention.  One working hypothesis is 
that C. difficile may be a foodborne pathogen and this hypothesis has been supported by 
the isolation of C. difficile from both food animals and retail meat (Jhung et al., 2008; 
Keel et al., 2007; Pirs et al., 2008; Rodriguez-Palacios et al., 2007; Simango and 
Mwakurudza, 2008; Weese et al., 2010; Zidaric et al., 2008).  An equally plausible 
explanation is that C. difficile is a ubiquitous organism and humans and food animals are 
exposed through a common environmental source.  Investigating the antimicrobial 
susceptibility patterns of C. difficile from human and food animal populations may help 
us understand the association between these populations.   
The objective of this study was to compare, both within and between host species, 
the antimicrobial susceptibility patterns of C. difficile strains arising from a closed and 
integrated human and swine population in Texas, U.S.A.   
 
Materials and Methods 
	 Swine composite fecal samples and human composite wastewater samples were 
collected from a closed, vertically integrated population in the state of Texas, previously 
described (Norman et al., 2011; Scott et al., 2005).  Details on sample collection and 
processing and isolation of C. difficile  have also been previously described (Norman et 
al., 2009;Norman et al., 2011;Scott et al., 2005).   
 Antimicrobial sensitivity testing was performed on the 523 C. difficile strains 
isolated from the population using a commercially available agar diffusion Epsilometer 
test (Etest:AB Biodisk North America, Inc., Piscataway, NJ).  Eleven different 
antibiotics were tested; ampicillin, chloramphenicol, tetracycline, amoxicillin/clavulanic 
acid, imipenem, cefoxitin, metronidazole, ciprofloxacin, clindamycin, 
piperacillin/tazobactam, and vancomycin.   
C. difficile strains were grown anaerobically (chamber conditions: 5% hydrogen, 
5% carbon dioxide, 90% nitrogen) for 48 hours on anaerobic Brucella plates (Anaerobe 
Systems, Walnut, CA) at 37C.  Colonies from the cultured plate were added to 1 ml of 
Viande-Levure (VL) broth (5g Tryptose (Becton, Dickinson, and Company (BD), Sparks, 
MD), 2.5 g yeast extract (BD), 2.5 g sodium chloride (VWR International, West Chester, 
PA), 1.2 g beef extract (BD), 0.3 g cysteine – HCl (Thermo Scientific, Rockford, IL), and 
1.25 g dextrose (BD) in 500 ml of de-ionized water) to make a McFarland standard of 
0.5.  Anaerobic Brucella agar plates were streaked per the instructions of the 
manufacturer (AB Biodisk North America, Inc.).  Two different antibiotic strips were 
placed on the plate in opposite directions and spaced about 2 cm apart.  Plates were 
incubated anaerobically at 37C and read at 48 hours, per the manufacturer’s instructions 
(AB Biodisk North America, Inc.).  Results were interpreted according to agar dilution 
	anaerobic breakpoints provided by the Clinical and Laboratory Standards Institute (CLSI) 
(Table 1) (CLSI, 2007).  Clinical and Laboratory Standards Institute anaerobic 
breakpoints are not provided for vancomycin or ciprofloxacin.  Vancomycin results were 
interpreted using the CLSI breakpoints for Gram-positive aerobes and ciprofloxacin 
results were interpreted based on trovafloxacin CLSI breakpoints for Gram-positive 
anaerobes (Table 1).  Quality control strains Bacterioides fragilis (ATCC #25285) and 
Bacterioides thetaiotaomicron (ATCC #29741) were tested and interpreted using the 
recommended CLSI breakpoints.    
 Antimicrobial susceptibility profiles for the host species were explored using 
Fisher’s exact test and non-parametric survival analysis.  Susceptibility to each antibiotic 
was coded as binary and explored both between and within host species using Fisher’s 
exact test (p<0.05) (Stata SE Release 10.1).  Isolates with susceptible and intermediate 
breakpoints were collapsed into one category and resistant isolates were placed into a 
second category to create binary variables.  Non-parametric survival analysis was used to 
assess within and between host differences in the distribution of minimum inhibitory 
concentration (MIC) values (Stata SE Release 10.1) (Stegeman et al., 2006).  Log-rank 
tests were used to test the equality of MIC distributions and Kaplan-Meier survival 
curves were produced to visually compare the distributions (State SE Release 10.1).  The 
MIC values were log transformed in order to improve the graphical interpretation of the 
data in the Kaplan-Meier survival curves.  The lowest MIC concentrations that 
completely inhibited 50% (MIC50) and 90% (MIC90) of the strains were calculated for 
each of the antimicrobials.  Results 
	 A total of 523 C. difficile strains were isolated from 5,228 swine fecal and human 
wastewater samples (Norman et al., 2011).  There were 252 strains isolated from 2,936 
swine fecal samples, including 175 from the farrowing barn, 14 from the nursery, 26 
from breeding swine, and 37 from grower/finisher swine.  There were 271 strains isolated 
from 2,292 human wastewater samples, including 131 from swine workers and 140 from 
non-workers. 
Swine binary 
 All 252 swine strains were susceptible to amoxicillin/clavulanic acid, 
piperacillin/tazobactam, and vancomycin (i.e., 100% susceptible, 0% resistant).    The 
majority of swine strains were resistant to cefoxitin (95.6%), ciprofloxacin (86.5%), and 
imipenem (58.7%) (Table 2).  Interestingly, 8.3% were resistant to metronidazole. In 
unconditional associations, there was a significant difference in susceptibility levels 
between swine production groups for ciprofloxacin (p<0.001) and tetracycline (p<0.01). 
Strains from the breeding group had the highest prevalence of resistance to tetracycline 
and the lowest prevalence of resistance to ciprofloxacin.  
Human binary 
 All 271 human strains were susceptible to amoxicillin/clavulanic acid, 
piperacillin/tazobactam, chloramphenicol, and vancomycin (i.e., 100% susceptible, 0% 
resistant).  The majority of human strains were resistant to cefoxitin (96.3%) and 
ciprofloxacin (98.5%).  Also, 13.3% were resistant to metronidazole.  There was no 
significant difference in susceptibility levels between the occupational group cohorts for 
any of the antimicrobials.  
Comparison of binary between and across host species 
	 In unconditional analyses when comparing susceptibility between host species, 
there was significantly (p<0.05) more resistance to ampicillin, clindamycin, and 
imipenem among swine strains and there was significantly (p<0.05) more resistance to 
ciprofloxacin among human strains (Table 2).  There was a significant difference in 
susceptibility levels across all 523 strains for chloramphenicol (p<0.05), ciprofloxacin 
(p<0.001), clindamycin (p<0.001), imipenem (p<0.001), and tetracycline (p<0.001).  
Strains from the older swine production groups (grower/finisher and breeding) had a 
higher prevalence of resistance to chloramphenicol compared to the younger swine 
production groups (farrowing and nursery) and human occupational group cohorts.  
Interestingly, the swine breeding production group had the highest prevalence of 
resistance to tetracycline.  There was a significant difference in susceptibility levels 
among seasons for clindamycin (p<0.05), imipenem (p<0.001), and tetracycline 
(p<0.001) across all 523 strains.  The highest percentage of resistance for clindamycin 
and imipenem was found in the winter and the highest for tetracycline was found in the 
spring. 
Comparison of MIC values within and between host species 
Non-parametric survival analysis was used to assess differences in the distribution 
of MIC values both within and between host species.  Significant (p<0.05) differences 
were found among host species with trends towards higher MIC values for imipenem, 
ampicillin, and clindamycin (Figure 1) in swine strains compared to human strains.  
Significant (p<0.05) trends towards higher MIC values for cefoxitin, ciprofloxacin 
(Figure 2), amoxicillin/clavulanic acid, piperacillin/tazobactam, metronidazole, and 
tetracycline were found in human strains compared to swine strains.  Key MIC values 
	were expressed graphically as MIC50 and MIC90, respectively.  A significant difference 
was found among swine production groups for MIC values for amoxicillin/clavulanic 
acid (p=0.04) and clindamycin (p=0.04) (Figure 3).  No significant differences (p>0.05) 
were found in susceptibility patterns between human occupational group cohorts. 
 
Discussion 
 Decreased antimicrobial susceptibility is an important issue when treating cases of 
C. difficile in both humans and swine.  The association between C. difficile in humans 
and swine is still unknown and there is evidence both supporting and refuting the 
possibility of transmission between species.  The unique nature of the current study 
allowed us to explore the antimicrobial susceptibility patterns among C. difficile isolated 
from an integrated population of humans and swine with little movement in or out of the 
system.  Previous studies have compared antimicrobial susceptibility patterns in human 
and swine populations; however, the populations were separate and unrelated (Debast et 
al., 2009; Goorhuis et al., 2008).  
 When comparing across host species, we found significantly more resistance to 
ampicillin, clindamycin, and imipenem among swine strains.  We also found significantly 
more resistance to ciprofloxacin among human strains compared to swine strains.   A 
study conducted in the Netherlands comparing swine C. difficile strains found similar 
antimicrobial susceptibility patterns for clindamycin, ciprofloxacin, metronidazole, and 
vancomycin with those reported for humans (Debast et al., 2009).  We also found similar 
patterns for metronidazole and vancomycin between human and swine. Another study 
conducted in the Netherlands also found no difference in antimicrobial susceptibility 
	patterns for clindamycin or ciprofloxacin between swine and humans (Goorhuis et al., 
2008).  The type of strains we recovered may affect the antimicrobial susceptibility 
profiles and provide a reason for the differences in susceptibility patterns between our 
study and the two Dutch studies.   
  In addition to differences found between host species, we also found differences 
in susceptibility patterns between swine production groups for ciprofloxacin, tetracycline, 
amoxicillin/clavulanic acid, and clindamycin.  We did not assess the antimicrobial usage 
data among these populations in the current study; however, varying rates of historical 
usage may be responsible for the significant differences found between host species and 
among swine production groups..  Alali et al. (2009) found that the relative odds of 
tetracycline resistance for Escherichia coli were significantly increased for 
chlortetracycline use in medicated feed across swine production groups in this study 
population (Alali et al., 2009).  Interestingly, the breeding group showed the highest 
prevalence of resistance to tetracycline and historically varying rates of chlortetracycline 
or oxytetracycline antibiotic treatment could explain these differences.  A recent study on 
the use of in-feed antimicrobials in swine production found that chlortetracycline had the 
highest estimated use in both the nursery and grower/finisher production groups (Apley et 
al., 2012).  The few swine that entered our swine population would have been breeding 
boars and these introduced boars may be responsible for the observed resistance to 
tetracycline.  
The significant differences in susceptibility patterns for clindamycin, imipenem, 
and tetracycline across seasons in the population (both human and swine) may also be 
explained by varying rates of antimicrobial use.  Reduced susceptibility was observed in 
	the winter months for clindamycin and imipenem and in the summer months for 
tetracycline.  This reduction may be reflective of an increase in certain conditions or 
illnesses that required antibiotic treatments during these seasons.  .  However, it should be 
noted that the reduced susceptibility to imipenem observed in the winter months could 
not be explained by differences in antimicrobial use in the swine population because 
carbapenems including imipenem are restricted from use in food animals. 
Valuable data may be lost when collapsing antimicrobial data into binary 
categories.  In addition to analyzing the binary data, survival analysis was used to assess 
the data across MIC values.  Similar results to the binary analysis were found when 
comparing across host species. Additionally, significantly increased MIC values were 
found in human strains to cefoxitin, amoxicillin/clavulanic acid, piperacillin/tazobactam, 
metronidazole, and tetracycline.  Significant MIC differences were also found among 
swine production groups for amoxicillin/clavulanic acid, and clindamycin.  As with the 
binary data analysis, no significant differences were observed across human occupational 
group cohorts.   
 Metronidazole and vancomycin are the two most commonly prescribed 
antimicrobials for treatment of C. difficile infections in humans.  The majority of clinical 
studies have not found resistance to either metronidazole or vancomycin (Huang et al., 
2009a; Taori et al., 2010).  All 523 swine and human strains in our study were 
susceptible to vancomycin.  However, we found 8.3% of swine strains and 13.3% of 
human strains were resistant to metronidazole (Figure 4).  Three studies have previously 
reported metronidazole resistance but at a lower prevalence (Brazier et al., 2001; Pelaez 
et al., 2002; Wong et al., 1999).  Clinical studies have also started to report decreasing 
	effectiveness of metronidazole for treatment of C. difficile infections (Musher et al., 
2005; Pepin et al., 2005).  One reason for the higher prevalence of metronidazole 
resistance found in the current study may be the source and type of C. difficile strains.  
One study has reported a greater prevalence of resistance to metronidazole in ribotype 
001 strains compared to 027, 106, and several other ribotypes (Baines et al., 2008).   
An interesting note about our samples is that many of the metronidazole resistant 
strains had MIC values that were initially classified as susceptible at 24 hours. However, 
at 48 hours there was additional hazy growth on the plate, resulting in an MIC value 
interpreted as resistant.  Others have also reported that certain strains appear to be 
heteroresistant and subpopulations show resistance to metronidazole at a slow rate 
(Huang et al., 2010).  .  The bimodal distribution of the metronidazole MIC values 
observed in our study would support the theory of a heteroresistant population (Figure 4). 
Huang et al. also found that metronidazole resistance was lost after three passages of 
freezing and thawing of these isolates. We ran our Etest® strips using pure cultures from 
plated enrichments. When we thawed a sample of our frozen strains found previously to 
be metronidazole resistant, we also found that the strains were now susceptible. 
There are several limitations with this study.  The study design and sample 
collection methods do not allow us to form definitive conclusions concerning the 
transmission of C. difficile between humans and swine.  The limitations of a cross-
sectional study are that prevalence is the only measurable outcome and it is difficult to 
determine if the exposure of interest occurred before the outcome was measured.  The 
human wastewater and swine fecal samples were aggregate samples and not collected on 
an individual level and results must be presented on the population level rather than the 
	individual level.  A sample positive for C. difficile may be the result of one or many 
infected individuals.  Finally little is known about the dynamics of C. difficile in 
wastewater samples.  Chemicals or compounds present in wastewater may have hindered 
or promoted the growth, preservation, or detection of C. difficile. 
Further research is needed to investigate the possible sources of community-
acquired C. difficile infection.  The current study provides evidence that occupational and 
food-borne exposures are less likely sources of community-acquired infections.  Genetic 
sequencing of the strains from these populations would provide further information about 
the similarity, differences, and evolutionary history between host species.  Further 
research is also needed to investigate the dynamics of metronidazole resistance in C. 
difficile strains. 
 Conclusion 
 The finding of differences in susceptibility patterns between host species and the 
finding of no difference between human occupational group cohorts provides some 
evidence that transmission between host species in this integrated population is less likely 
than within species or from point sources.  The antimicrobial usage data for the host 
populations were not assessed in this study; however, varying rates of usage (especially 
for swine) may be responsible for differences seen between and within host species. The 
high level of resistance to metronidazole in both the swine and human wastewater 
samples is of concern and warrants further investigation.  
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